These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17214969)

  • 41. Structural basis of the interaction of the breast cancer oncogene LMO4 with the tumour suppressor CtIP/RBBP8.
    Stokes PH; Liew CW; Kwan AH; Foo P; Barker HE; Djamirze A; O'Reilly V; Visvader JE; Mackay JP; Matthews JM
    J Mol Biol; 2013 Apr; 425(7):1101-10. PubMed ID: 23353824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting mechanism of the retinoblastoma tumor suppressor by a prototypical viral oncoprotein. Structural modularity, intrinsic disorder and phosphorylation of human papillomavirus E7.
    Chemes LB; Sánchez IE; Smal C; de Prat-Gay G
    FEBS J; 2010 Feb; 277(4):973-88. PubMed ID: 20088881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The LxCxE pRb interaction domain of cyclin D1 is dispensable for murine development.
    Landis MW; Brown NE; Baker GL; Shifrin A; Das M; Geng Y; Sicinski P; Hinds PW
    Cancer Res; 2007 Aug; 67(16):7613-20. PubMed ID: 17699765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular dissection of Rab11 binding from coiled-coil formation in the Rab11-FIP2 C-terminal domain.
    Wei J; Fain S; Harrison C; Feig LA; Baleja JD
    Biochemistry; 2006 Jun; 45(22):6826-34. PubMed ID: 16734419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The large subunit of replication factor C promotes cell survival after DNA damage in an LxCxE motif- and Rb-dependent manner.
    Pennaneach V; Salles-Passador I; Munshi A; Brickner H; Regazzoni K; Dick F; Dyson N; Chen TT; Wang JY; Fotedar R; Fotedar A
    Mol Cell; 2001 Apr; 7(4):715-27. PubMed ID: 11336696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chibby forms a homodimer through a heptad repeat of leucine residues in its C-terminal coiled-coil motif.
    Mofunanya A; Li FQ; Hsieh JC; Takemaru K
    BMC Mol Biol; 2009 May; 10():41. PubMed ID: 19435523
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kinetic recognition of the retinoblastoma tumor suppressor by a specific protein target.
    Chemes LB; Sánchez IE; de Prat-Gay G
    J Mol Biol; 2011 Sep; 412(2):267-84. PubMed ID: 21787785
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB.
    Hagemeier C; Bannister AJ; Cook A; Kouzarides T
    Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1580-4. PubMed ID: 8434021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes.
    Prichard MN; Sztul E; Daily SL; Perry AL; Frederick SL; Gill RB; Hartline CB; Streblow DN; Varnum SM; Smith RD; Kern ER
    J Virol; 2008 May; 82(10):5054-67. PubMed ID: 18321963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RB family tumor suppressor activity may not relate to active silencing of E2F target genes.
    Vormer TL; Wojciechowicz K; Dekker M; de Vries S; van der Wal A; Delzenne-Goette E; Naik SH; Song JY; Dannenberg JH; Hansen JB; Te Riele H
    Cancer Res; 2014 Sep; 74(18):5266-76. PubMed ID: 25056122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein Phosphatase 1 binds strongly to the retinoblastoma protein but not to p107 or p130 in vitro and in vivo.
    Dunaief JL; King A; Esumi N; Eagen M; Dentchev T; Sung CH; Chen S; Zack DJ
    Curr Eye Res; 2002 May; 24(5):392-6. PubMed ID: 12434308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding of the LXCXE insulin motif to a hexapeptide derived from retinoblastoma protein.
    Radulescu RT; Bellitti MR; Ruvo M; Cassani G; Fassina G
    Biochem Biophys Res Commun; 1995 Jan; 206(1):97-102. PubMed ID: 7818556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
    Sellers WR; Rodgers JW; Kaelin WG
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
    Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
    J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest.
    Dunaief JL; Strober BE; Guha S; Khavari PA; Alin K; Luban J; Begemann M; Crabtree GR; Goff SP
    Cell; 1994 Oct; 79(1):119-30. PubMed ID: 7923370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment.
    Welch PJ; Wang JY
    Genes Dev; 1995 Jan; 9(1):31-46. PubMed ID: 7828850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation.
    Kehn K; Fuente Cde L; Strouss K; Berro R; Jiang H; Brady J; Mahieux R; Pumfery A; Bottazzi ME; Kashanchi F
    Oncogene; 2005 Jan; 24(4):525-40. PubMed ID: 15580311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase.
    Ferreira R; Magnaghi-Jaulin L; Robin P; Harel-Bellan A; Trouche D
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10493-8. PubMed ID: 9724731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro.
    Hagemeier C; Cook A; Kouzarides T
    Nucleic Acids Res; 1993 Nov; 21(22):4998-5004. PubMed ID: 8255752
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor.
    Lee C; Chang JH; Lee HS; Cho Y
    Genes Dev; 2002 Dec; 16(24):3199-212. PubMed ID: 12502741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.